M&A Deal Summary |
|
---|---|
Date | 2021-07-13 |
Target | AOC |
Sector | Chemicals |
Buyer(s) | Lone Star Funds |
Sellers(s) | CVC Capital Partners |
Deal Type | Secondary Buyout |
Deal Value | 2.4B USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1995 |
PE ASSETS | 85.0B USD |
Size | Mega |
Type | Sector Agnostic |
Lone Star Funds is a global private investment firm focused on investing across several strategies. The Firm's primary investment activity surrounds financial services and real estate. Lone Star generally looks to acquire distressed debt and equity assets including corporate, commercial real estate, single family residential and consumer debt products as well as banks and asset rich operating companies. Lone Star was formed in 1995 and is based in Dallas, Texas with additional offices across Western Europe and Asia.
DEAL STATS | # |
---|---|
Overall | 19 of 26 |
Sector (Chemicals) | 3 of 3 |
Type (Secondary Buyout) | 10 of 13 |
State (Tennessee) | 2 of 2 |
Country (United States) | 8 of 12 |
Year (2021) | 1 of 2 |
Size (of disclosed) | 4 of 11 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-01-08 |
Stark Group
Frederiksberg, Denmark Stark Group is a distributor and retailer of building materials to clients from the Nordic region. Stark Group was formed in 1896 and is based in Frederiksberg, Denmark. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-08-16 |
Arclin
Alpharetta, Georgia, United States Arclin is a manufacturer and formulator of proprietary surface overlays and specialty resins primarily for the residential building products market, as well as industrial, furniture, and non-residential construction markets. The Company serves high-growth applications, which are expected to continue benefiting significantly from positive trends in the market. It's IP-protected, proprietary products and assets drive key performance characteristics, and the Company maintains long-term relationships with its blue-chip customers and suppliers. Arclin was founded in 1992 and is based in Alpharetta, Georgia. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1981 |
PE ASSETS | 177.0B EUR |
Size | Mega |
Type | Sector Agnostic |
CVC Capital Partners is a global private equity firm focused on investments in large companies located in Europe, North America, and Asia. CVC looks for opportunities with stable cash flows and talented management, and will consider businesses in a variety of industries. Target sectors include textiles, industrial products, waste management, building materials, energy/utilities, business services, financial services, distribution, healthcare, media, semiconductors, and gaming. CVC can handle transactions valued from €200 million to €10 billion. CVC Capital Partners was formed in 1981 and is based in Luxembourg.
DEAL STATS | # |
---|---|
Overall | 160 of 173 |
Sector (Chemicals) | 8 of 8 |
Type (Secondary Buyout) | 39 of 42 |
State (Tennessee) | 2 of 2 |
Country (United States) | 14 of 14 |
Year (2021) | 9 of 15 |
Size (of disclosed) | 11 of 54 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-12 |
Aleph Holding
Dubai, United Arab Emirates Aleph Holding is a provider of digital advertising sales for the leading digital media platforms - such as Twitter, Facebook, LinkedIn, Snapchat, Twitch and TikTok amongst others - giving access to new and under-served markets, while providing a complete suite of services that help advertisers maximise the value of their digital marketing investments. Aleph Holding was founded in 2020 and is based in Dubai, United Arab Emirates. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-19 |
Pharmathen
Amstelveen, Netherlands Pharmathen is a European pharmaceutical company that focuses on developing, manufacturing, and out-licensing complex generic pharmaceutical products. Pharmathen's differentiated B2B model attracts a blue-chip customer base of more than 215 generic pharmaceutical companies, which it serves from two US/EU-approved manufacturing facilities in Greece. Pharmathen was founded in 1969 and is based in Amstelveen, Netherlands. |
Buy | €1.6B |